The corporation has invested USD 12 million to develop a topical gel that is can prevent the transmission of HIV. The research was carried out at a major University. The gel is based on antibodies that bind to the mucins coating and the mucosa tissue. The gel is mass produced, and extremely cost effective.

Posted Jul 18, 2016

Did you know that social networking is a great way to buy a business? Sign up now and we'll show you how.

By clicking "Sign Up" you confirm that you accept the Terms of Use and Privacy Policy, including cookie use.

Suggested Searches

Disclaimer: MergerNetwork has not independently verified any of the information in this listing and makes no warranty as to its accuracy or completeness.